Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels that mediate excitatory neurotransmission throughout the central nervous system (CNS).^[@ref1]^ Aberrancies in iGluR function result in a wide range of neurological diseases.^[@ref1]−[@ref4]^ Glutamate, the primary neurotransmitter at almost all synapses in the CNS, is released from presynaptic terminals and binds to postsynaptic iGluRs, which in response open their ion channels for the flow of cations, rapidly depolarize the postsynaptic membrane, and initiate signal transduction in the postsynaptic neuron. The iGluR family of integral membrane proteins includes four subtypes in vertebrates: α-amino-3-hydroxy-5-methyl-4-isoaxazolepropionic acid (AMPA), kainate (KA), *N*-methyl-[d]{.smallcaps}-aspartate (NMDA), and δ-receptors. Each iGluR family member exhibits specific kinetic and pharmacological properties, in addition to playing unique roles in neurotransmission.

Despite their diversity, iGluRs share a common modular structural design ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref5],[@ref6]^ All iGluRs are assemblies of four similar or identical subunits (A--D) organized into a layered architecture. A large extracellular domain (ECD) comprises the amino-terminal domain (ATD) layer that is necessary for assembly, trafficking, and functional regulation of the receptor^[@ref1],[@ref7]^ and the ligand binding domain (LBD)^[@ref8]^ layer, which sits below the ATD and harbors binding sites for ligands that activate, modulate, or antagonize the receptor. Below the ATD and LBD layers is the transmembrane domain (TMD)^[@ref9]^ that forms a channel for cations to flow through the postsynaptic membrane. The cytoplasmic carboxy-terminal domains (CTDs), which are involved in receptor localization and regulation,^[@ref10]^ have widely different sizes depending on the iGluR subunit. These likely form an intracellular fourth layer but have so far evaded structural determination.

![iGluR structural architecture and domain arrangement. (a) Crystal structure of a homotetrameric AMPAR composed of GluA2 subunits in the closed, competitive antagonist ZK200775-bound state \[Protein Data Bank (PDB) entry 3KG2\] viewed parallel to the membrane. Each of the four GluA2 subunits is colored differently: green (A), red (B), blue (C), and yellow (D). ZK200775 molecules are shown as space-filling models. (b) Single GluA2 subunit (A/C), rainbow-colored from blue (N-terminus) to red (C-terminus). The LBD upper (D1) and lower (D2) lobes are indicated by gray, dashed contours. (c) Representations of each iGluR domain layer (ATD, LBD, and TMD) viewed extracellularly, parallel to the axis of the receptor overall 2-fold rotational symmetry. The axes of local 2-fold symmetry in the ATD and LBD dimers are indicated with small black ovals and those of overall 2-fold symmetry with large black ovals, and local 4-fold symmetry in the TMD is indicated with a black square. Gray, dashed contours encapsulate local dimer pairs in the ATD and LBD layers.](bi-2017-008918_0001){#fig1}

Overall, the structures of iGluRs are 2-fold symmetric, unique for tetrameric ion channels, where cross-subunit interactions and symmetry partners swap along the three-layered topology of the receptors^[@ref11]^ ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c). In the ATD layer, local dimers between subunits A and B and subunits C and D form on each side of the overall 2-fold symmetry axis, with a cross-dimer interface between subunits B and D. In the LBD layer, the local dimer pairs are switched, subunits A and D and subunits B and C, and the cross-dimer interface is formed between subunits A and C. Each LDB is comprised of two polypeptide stretches, S1 and S2, which form a clamshell structure, with ligand binding occurring in the middle, between the LDB upper (D1) and lower (D2) lobes ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b). When the agonist binds, the LBD clamshells close to induce channel opening in the TMD. The TMD, which has an inverted orientation in the membrane compared to voltage-gated ion channels, consists of three transmembrane helices (M1, M3, and M4) and a re-entrant intracellular loop M2 between helices M1 and M3. The LBDs are tethered to the TMD through the flexible polypeptide linkers S1--M1, M3--S2, and S2--M4. These linkers communicate conformational changes in the LBD induced by binding of the ligand to the TMD. While the linker region is still 2-fold symmetric, the membrane-residing TMD is nearly 4-fold symmetric. The M3 segments line the extracellular portion of the ion channel pore, while M1 and M4 surround M3s and form the ion channel periphery. The re-entrant loop M2 includes an N-terminal helix, which forms extensive cross-subunit interfaces, and an extended C-terminal region, which lines the intracellular portion of the ion channel pore and forms a selectivity filter.

While the structures of full-length receptors have been well-studied by X-ray crystallography^[@ref11]−[@ref17]^ and cryo-electron microscopy (cryo-EM),^[@ref13],[@ref18]−[@ref24]^ the process by which iGluRs bind glutamate to conduct cations into the postsynaptic density has remained elusive. Only recently have cryo-EM studies succeeded in determining the first high-resolution structure of an activated, glutamate-bound AMPA receptor (AMPAR) in a conducting state^[@ref25]^ and also in visualizing the conformational changes in the entire receptor during desensitization.^[@ref26]^ Coupled with earlier X-ray crystallographic studies of full-length AMPARs in unliganded^[@ref13],[@ref17]^ (apo) and pre-active states,^[@ref12],[@ref13],[@ref16]^ we can begin to visualize the entire gating mechanism of iGluRs using AMPARs as a template. This Perspective outlines recent progress in AMPAR structural biology to provide an in-depth visualization of the complete iGluR gating mechanism for the first time.

Gating in AMPARs {#sec2}
================

We refer to gating in iGluRs, and in this specific case of AMPARs, as the general series of conformational changes in the receptor that occur upon ligand binding or unbinding to open or close the ion channel and affect the functional state of the receptor. A whole-cell patch-clamp current in response to a prolonged application of agonist glutamate ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a) illustrates three major iGluR gating functions: activation, desensitization, and deactivation. iGluR gating functions can also be described by a simplified kinetic model that includes closed, pre-active, open, and desensitized states ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b). In the absence of agonist (A), the receptors reside in a resting, nonconducting state C (closed). The concentration-dependent process of agonist binding (C to C~A~ transition) is immediately followed by conformational changes that place the receptor in a pre-active state (P), where it is ready to follow one of the two major functional routes: the receptor can either convert into a conducting (indicated by an asterisk) state O (open) or adopt an active but nonconducting state D (desensitized). The P~A~ to O~A~ transition is much faster than the P~A~ to D~A~ transition and defines the fast, submillisecond time scale rise in the inward current signifying the activation process ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a). Typically, however, the equilibrium between agonist-bound states is strongly shifted toward D~A~, and the majority of the receptors (95--99% for AMPARs) undergo the transition from O~A~ to D~A~, underlying the current decline phase in the continuous presence of agonist and signifying the desensitization gating process ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a). Note that there is no direct transition between O~A~ and D~A~^[@ref27]^ and receptors have to visit P~A~ between those states. After agonist removal, receptors undergo the transition from all agonist-bound states (the majority are in D~A~) to the closed state C defining the recovery of the steady state current to zero in the process of deactivation ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a).

![Functional recording and kinetic model of iGluR gating. (a) Representative whole-cell patch-clamp current recorded at a −60 mV membrane potential from a HEK-293 cell expressing GluA2 in response to a 0.5 s application of the agonist glutamate (black bar). Current components that are mainly determined by the three major gating processes, activation, desensitization, and deactivation, are indicated by arrows. (b) Simplified kinetic model of iGluR gating, with closed (C), pre-active (P), open (O), and desensitized (D) states. The agonist-bound states are indicated by "A", and the conducting state is indicated by an asterisk. Colors associated with each state C (blue), P (green), O (magenta), and D (orange) are used throughout this Perspective for structural representations.](bi-2017-008918_0002){#fig2}

Despite the fact that the basic gating processes can be described by the simplified kinetic model ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b), the detailed analysis of iGluR activity typically requires more complicated kinetic models.^[@ref16],[@ref27]−[@ref30]^ For example, AMPAR single-channel currents show multiple conductance levels,^[@ref31],[@ref32]^ and occupancy of these levels depends on the agonist type and concentration,^[@ref30],[@ref33]−[@ref37]^ reflecting different extents of pore opening as well as the activation state and coupling efficiency for each of the four contributing receptor subunits. While kinetic models can account for these multiple conductance levels by introducing additional subunit-specific states, the structural bases underlying transitions between these states remain obscure. We will therefore discuss how the kinetic transitions occur at the structural level in the framework of the simplified kinetic model, based on cryo-EM and X-ray crystallography structures of full-length AMPARs.

Structures Describing the AMPAR Gating States {#sec3}
=============================================

Since the first structure of a full-length iGluR^[@ref11]^ (AMPAR subtype GluA2) in the closed, competitive antagonist ZK200775 (ZK)-bound state was determined, significant progress has been made by both crystallographic and cryo-EM studies, which revealed the key states in the AMPAR gating mechanism ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). For example, two available apo state GluA2 crystal structures^[@ref13],[@ref17]^ can be used to describe closed state C in the gating model. [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a illustrates one of the two, GluA2~Apo~,^[@ref17]^ with a more symmetrical arrangement of domains and a better-resolved TMD. Also determined by crystallography, there is a range of agonist-bound structures,^[@ref12],[@ref13],[@ref16]^ with partially closed LBD clamshells bound to agonist and closed ion channels. Although it is yet unclear how functionally identified pre-active states relate to these structures, in the first approximation they can serve as models of P~A~. In this Perspective, we use the crystal structure of GluA2 in complex with the partial agonist nitrowillardiine (NOW)^[@ref16]^ (GluA2~NOW~) as a representative structure for the pre-active state P~A~ ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b).

![Structures of AMPARs and AMPAR complexes representing different gating conformations. Shown are the entire structures viewed parallel to the membrane (top row) or their TMDs viewed extracellularly (bottom row). (a) Crystal structure of GluA2 in the absence of ligands, GluA2~Apo~ (PDB entry 5L1B), representing the resting, closed state (C). (b) Crystal structure of GluA2 bound to the partial agonist nitrowillardiine (NOW), GluA2~NOW~ (PDB entry 4U4F), representing the pre-active state (P). (c) Cryo-EM structure of the GluA2--GSG1L complex bound to the full agonist quisqualate (Quis), GluA2--GSG1L~Quis~ (PDB entry 5VHZ), representing the desensitized state (D). (d) Cryo-EM structure of the GluA2--STZ complex bound to the full agonist glutamate (Glu) and positive allosteric modulator cyclothiazide (CTZ), GluA2--STZ~Glu+CTZ~ (PDB entry 5WEO), representing the open state (O). All ligands are shown as space-filling models. AMPAR subunits are colored purple (A and C) and green (B and D), with auxiliary subunits colored red (GSG1L) or blue (STZ).](bi-2017-008918_0003){#fig3}

Additional structures of AMPARs that we use as structural representations of states in the AMPAR gating mechanism were determined using cryo-EM in the presence of transmembrane auxiliary subunits. These auxiliary subunits assemble with the majority of AMPARs *in vivo* and alter their kinetics and pharmacology to specifically modulate receptor function at various synapses throughout the CNS. Several comprehensive reviews describe these regulatory subunits in great detail.^[@ref38]−[@ref41]^ One such regulatory subunit, germline-specific gene1-like (GSG1L),^[@ref42],[@ref43]^ reduces the AMPAR channel open probability and favors nonconducting states of the receptor.^[@ref44],[@ref45]^ Cryo-EM was used to determine the structure of the GluA2--GSG1L complex in the presence of the antagonist ZK^[@ref25]^ (GluA2--GSG1L~ZK~) to an overall resolution of 4.6 Å, with a higher local resolution in the TMD (∼4 Å) to provide the most complete closed state iGluR channel structure to date. As this structure is nearly identical to that of GluA2~Apo~ yet has better-resolved molecular details in the TMD, we use GluA2--GSG1L~ZK~ to describe closed state C in the gating mechanism throughout the remainder of this Perspective.

Because GSG1L also favors AMPAR desensitization, we determined the first AMPAR structure in the desensitized state^[@ref26]^ by applying cryo-EM to the GluA2--GSG1L complex bound to the high-affinity agonist quisqualate (Quis), which slows down recovery from desensitization compared to the lower-affinity agonist glutamate.^[@ref46]^ We use this GluA2--GSG1L~Quis~ structure ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}c) to represent the desensitized state D~A~ in the AMPAR gating model ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b). Contrary to GSG1L, the auxiliary subunit stargazin (STZ) increases the channel open probability and favors the AMPAR open state.^[@ref37],[@ref47]^ Correspondingly, we applied cryo-EM to the GluA2--STZ complex bound to the agonist glutamate and the positive allosteric modulator cyclothiazide (CTZ) to determine the first high-resolution (3--4 Å local resolution throughout the TMD) structure of an activated iGluR with the ion channel in the open state.^[@ref25]^ We use this GluA2--STZ~Glu+CTZ~ structure ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}d) to represent the open state O~A~ in the AMPAR gating model.

We assume that the structures describing the gating states of AMPARs in the absence or presence of auxiliary subunits are largely similar. This assumption is strongly supported by nearly identical structures of AMPARs in the apo or antagonist-bound states in the absence^[@ref11]−[@ref13],[@ref16],[@ref20],[@ref48]^ or presence^[@ref20],[@ref21],[@ref25],[@ref26]^ of auxiliary subunits. However, such a comparison is not yet available for other gating states. In addition, all currently available structures of AMPAR receptor complexes are with claudin-like auxiliary subunits,^[@ref20],[@ref21],[@ref25],[@ref26],[@ref49]^ while other types of auxiliary subunits may exert stronger influences on AMPAR conformations. We also model gating transitions by morphing the discrete gating states. Perhaps intermediate gating states, which are currently unavailable, and unapproachable by traditional X-ray crystallography and cryo-EM methods, will be resolved in the future using nuclear magnetic resonance spectroscopy, X-ray free electron lasers, or time-resolved cryo-EM.

LBD: The Gating Initiation Domain {#sec4}
=================================

LBDs are the chemical recognition sites in AMPARs, acting as gating initiation domains to communicate the presence or absence of ligands to the rest of the receptor and TMD in particular. In the resting or closed state, C, the clamshell of an individual LBD ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a and [Movie 1](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00891/suppl_file/bi7b00891_si_001.avi)) is maximally open (true for both the apo and antagonist-bound states). When the agonist binds, the clamshell closes, with D2 moving toward D1, reducing the size of the cleft between D1 and D2.^[@ref50]^ Full clamshell closure, resulting in the maximally open (O~A~) or desensitized (D~A~) states, is characterized by a 26° swing of D2 toward D1. Intermediate clamshell closure (11° in the GluA2~NOW~ structure) characterizes the pre-active state, P~A~, where the channel remains completely closed and no conformational changes associated with opening or desensitization have yet happened (see below). Recent biophysical studies suggested that binding of any given agonist can induce different extents of LBD clamshell closure, but the extent of iGluR activation depends on the probability of the LBD clamshell to occupy its completely closed conformation.^[@ref30],[@ref51]−[@ref56]^ Accordingly, compared to full agonists, partial agonists less frequently elicit complete closure of the LBD clamshell and induce channel opening with lower probability. Consistent with this idea, incompletely closed clamshells are easier to capture in structures with partial agonists, especially if these structures are stabilized by crystal contacts or complexes with auxiliary subunits.^[@ref13],[@ref16],[@ref49]^

![Structural rearrangements in individual LBDs and LBD dimers during gating. (a) Superposition of LBD monomers from GluA2--GSG1L~ZK-1~ (blue, PDB entry 5WEK), GluA2~NOW~ (green, PDB entry 4U4F), GluA2--GSG1L~Quis~ (orange, PDB entry 5VHZ), and GluA2--STZ~Glu+CTZ~ (magenta, PDB entry 5WEO) structures based on the upper lobe D1. Movement of the lower lobe D2 relative to the GluA2--GSG1L~ZK-1~ structure is illustrated with arrows of the corresponding color. (b--d) Superposition of LBD dimers from GluA2--GSG1L~ZK-1~ and (b) GluA2~NOW~, (c) GluA2--GSG1L~Quis~, or (d) GluA2--STZ~Glu+CTZ~. Cα atoms of S635 and S741 are shown as spheres of the corresponding color with cross-dimer distances between them indicated.](bi-2017-008918_0004){#fig4}

At the level of LBD dimers ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b--d and [Movie 2](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00891/suppl_file/bi7b00891_si_002.avi)), it becomes apparent how the same extent of closure of the individual LBD clamshells can result in the completely different gating functions of activation and desensitization.^[@ref50],[@ref57],[@ref58]^ We use distances between Cα atoms of S741 and S635 to measure changes in the LBD dimer D1--D1 and D2--D2 lobe separation, respectively, in different gating states ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b--d). Because of the back-to-back dimer arrangement, maintaining the D1--D1 interface during activation allows conversion of the individual clamshell closures to dramatic separation of the D2 lobes ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}c). It is this separation that is used to open the iGluR ion channel. Alternatively, the D1 lobes of the LBD dimers become separated from each other during desensitization as a result of back-to-back rolling of the individual LBDs. Because the individual LBD clamshells remain maximally closed, separation of the D1 lobes brings the D2 lobes closer together ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}d), releasing strain on the linkers leading to the ion channel and thus leaving it in a nonconducting state. However, before the LBD clamshells proceed with one of these two dramatically different conformational pathways, they first reach a pre-active conformation with partially closed clamshells ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b). In essence, P~A~ is a bifurcation point in the iGluR gating energy landscape: here the energy of agonist binding goes into partial closure of the individual LBD clamshells, creating strain on both the D1--D1 interface and the linkers connecting D2s to the ion channel; this energy can further be used to either break the M3 bundle seal and open the ion channel for conductance or rupture the D1--D1 interface to keep the D2 lobes close together and not disturb the closed channel conformation.

The changes in the LBD local dimers happen 2-fold symmetrically across the overall 2-fold rotational symmetry axis of the receptor, and this paired movement is what acts to change the gating state of the TMD below ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"} and [Movie 3](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00891/suppl_file/bi7b00891_si_003.avi)). In the resting, closed state (C), the LBDs create a tight arrangement around the central receptor axis; the state of the ion channel is directly affected by movement of LBDs away from this axis to strain the LBD--TMD linkers. Only a little gross difference in the overall LBD layer arrangement is observed between C and P~A~ ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}a). Much more significantly, the LBD layer expands in O~A~, where the separation of the D2 lobes in local LBD dimers results in an overall movement of the LBDs away from the 2-fold symmetry axis ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}b), which ultimately adds tension on the LBD--TMD linkers to open the ion channel. In the desensitized state, D~A~, regardless of maximum clamshell closure in individual LBDs, the ruptured D1--D1 LBD dimer interfaces allow subunits A and C LBDs to rotate 14° away from their dimer pair partners ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}c). These structural rearrangements result in the loss of the local 2-fold rotational symmetry in the LBD dimers, make the LBD layer appear more 4-fold symmetrical, and bring the individual LBDs closer to the axis of the overall 2-fold symmetry ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}c), thus allowing the ion channel to stay closed.

![Structural rearrangements in the LBD tetramer during gating. Superposition of LBD tetramers from GluA2--GSG1L~ZK-1~ (blue, closed state) and (a) GluA2~NOW~ (green, pre-active state), (b) GluA2--STZ~Glu+CTZ~ (magenta, open state), or (c) GluA2--GSG1L~Quis~ (orange, desensitized state) viewed from the TMD along the axis of the overall 2-fold receptor symmetry (large black ovals in the middle). Cα atoms of S635 are shown as spheres of the corresponding color, connected by straight lines. Broadening of the LBD layer in the open state and rotation of the A and C monomers in the desensitized state are indicated by red arrows. Green arrows in panel c point to the cleft between the desensitized state LBD protomers, signifying the loss of local 2-fold symmetry in LBD dimers (small ovals) and 3-fold smaller intradimer interfaces.](bi-2017-008918_0005){#fig5}

LBD--TMD Linkers: The Gating Transmission Elements {#sec5}
==================================================

The aforementioned changes in the LBD layer are transmitted to the ion channel by means of the LBD--TMD linkers. Because of the 2-fold symmetrical arrangement of the LBDs, the linkers connecting them to the pseudo-4-fold symmetrical TMD form two conformationally distinct diagonal pairs that play different roles in the geometric and energetic coupling of protein domains in subunits A and C versus subunits B and D and correspondingly define the distinct roles of the two pairs of diagonal subunits in iGluR gating. During gating, the three pairs of LBD--TMD linkers, S1--M1, M3--S2, and S2--M4, in the A and C as well as B and D diagonal pairs undergo significant conformational changes ([Movie 4](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00891/suppl_file/bi7b00891_si_004.avi), [Movie 5](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00891/suppl_file/bi7b00891_si_005.avi), and [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). The principal changes that drive the ion channel to open or close occur in the B and D subunit M3--S2 linkers, which splay apart by 12 Å to pull on the M3 pore-forming helices ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}b). The same linkers in the A and C subunits undergo little change ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}a) and move closer together by 1 Å. These observations are in good agreement with studies showing that the B and D subunits play a more important and direct role in gating than the A and C subunits do.^[@ref59],[@ref60]^ Similarly, the S1--M1 linkers in the B and D subunits splay apart by 13 Å, while the linkers in the A and C subunits separate by only 5 Å. In the last set of LBD--TMD linkers, the S2--M4 linkers, the B and D subunits maintain their relative positioning. Surprisingly, drastic changes are observed in the A and C linkers, which include complete unwinding of the pre-M4 helices and stretching of the S2--M4 linkers toward the central pore axis to contribute to the ion permeation pathway ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}c,d and [Movie 4](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00891/suppl_file/bi7b00891_si_004.avi)). This finding helps to explain why the M4 segments are critical for iGluR tetrameric functional assembly^[@ref61]−[@ref63]^ and why mutations in this region are related to human pathologies and have dramatic effects on iGluR gating kinetics.^[@ref64]−[@ref66]^

![Structural rearrangements in the ion channel during opening. (a and b) Close-ups of the superposition of pore-lining domains M2 and M3 and M3--S2 linkers in subunits (a) A and C and (b) B and D of GluA2--GSG1L~ZK-1~ (blue, closed state) and GluA2--STZ~Glu+CTZ~ (magenta, open state). Cα atoms of S635 are shown as spheres of the corresponding color with cross-dimer distances between them indicated. Residues forming the upper (T617, A621, T625, and M629) and lower (Q586) gates as well as the gating hinge alanine A618 are shown as sticks. The location of the gating hinge in subunits B and D is indicated by green arrows. Extracellular view of the ion channel in (c) GluA2--GSG1L~ZK-1~ and (d) GluA2--STZ~Glu+CTZ~. Note the widening of the ion channel pore and the unwinding of the pre-M4 helix in the open state structure.](bi-2017-008918_0006){#fig6}

TMD: The Gating Effector Domain {#sec6}
===============================

Conformational changes that originate in the LBDs are communicated by the LBD--TMD linkers to the TMD, where the ion channel pore opens or closes depending on the state of the LBD layer. In the closed state, the bundle crossing of the M3 helices occludes the ion permeation pathway, creating an upper gate, contributed by A617, A621, and T625 from all four subunits^[@ref11]^ ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). Unique to subunits A and C is an extended M3 helix, where the side chains of M629 protrude toward the center of the pore and also contribute to the upper gate. This region of the pore is 2-fold symmetric, and in subunits B and D, M629 is part of the M3--S2 linker and does not contribute to the upper gate. Newly identified in the GluA2--GSG1L~ZK~ cryo-EM structure^[@ref25]^ is a second, lower channel gate created by the Q/R site glutamines, Q586, which extend their side chains from the tips of the M2 loops toward the pore center. In neurons, brain compartment-specific mRNA editing of the GluA2 subunit Q/R site (glutamine to arginine) dramatically changes AMPAR function: the presence of arginine makes AMPARs Ca^2+^-impermeable and resistant to polyamine block.^[@ref67]−[@ref74]^ On the basis of the GluA2--GSG1L~ZK~ structure, replacement of the Q586 glutamine with arginine will place positively charged guanidinium groups in the middle of the ion channel pore, likely causing interference with Ca^2+^ permeation and polyamine block due to electrostatic repulsion.

For the channel to open, forces must be applied to the TMD via the LBD--TMD linkers. As discussed above, the changes in the LBD--TMD linkers are largely 2-fold symmetric, and therefore, it is not surprising that the changes at the top of the ion channel are also 2-fold symmetric^[@ref25]^ ([Movie 6](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00891/suppl_file/bi7b00891_si_006.avi) and [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). Upon opening, the M3 helices in subunits A and C become one helical turn shorter, and methionines M629, which previously occluded the ion channel, flip away from the central pore axis. The major structural changes, however, occur in the M3 segments of subunits B and D, where a kink at A618 pulls the helices away from the pore axis, opening the upper gate for ion permeation. This A618 gating hinge, which is unique to tetrameric ion channels, is in the middle of "SYTANLAAF", the most highly conserved motif in iGluRs.^[@ref9]^ Therefore, we predict that the mechanism of ion channel opening will be largely similar across the entire iGluR family. At the lower gate, Q586 side chains flip outward from the ion permeation pathway upon channel opening and no longer occlude the pore. The cytoplasmic part of the selectivity filter, formed by extended regions of M2 and contributed to by the backbone carbonyls of Q587, G588, and C589, is better resolved in the open state GluA2--STZ~Glu+CTZ~ cryo-EM structure^[@ref25]^ and appears to be more stable than in the closed channel structures. The pore seems to be wider here, as well, which is supported by the appearance of a clear density in the center of the pore, likely representing permeant sodium ions.^[@ref25]^ Together, the conformational changes in the TMD suggest an iris-like mechanism of channel opening, similar to that of K^+^ channels, where the M3 pore-forming helices splay away from the central pore axis to allow for ion permeation ([Movie 6](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00891/suppl_file/bi7b00891_si_006.avi)).

The phenomenon of multiple conductance levels in AMPAR single-channel currents reflects changes in the pore dilation that are directly related to LBD occupancy by agonist and conformational changes in individual receptor subunits. We propose that the highest conductance level corresponds to the fully dilated pore, when the ion permeation is relieved at both channel gates by all four subunits. In turn, incomplete occupancy of LBDs by agonist results in asymmetric conformational changes in individual subunits, partial opening of the upper, lower, or both gates, and, as a result, incomplete dilation of the pore that can support ion permeation only at lower conductance levels.

Interestingly, the structural changes that occur during ion channel opening in the AMPAR TMD and LBD--TMD linkers interfere with the binding of small-molecule noncompetitive inhibitors. These inhibitors, including perampanel (PMP, the only FDA-approved drug targeting AMPARs), GYKI-53655, and CP-465022, have been recently identified crystallographically to bind in the upper region of the TMD, termed the ion channel extracellular collar.^[@ref17]^ Access to this site, formed by the pre-M1 helix and the extracellular portions of M1, M3, and M4, is open for noncompetitive inhibitor binding in the resting, closed state of the receptor ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}a,b). In contrast, the upper portions of the kinked M3 helices in subunits B and D occlude access to the noncompetitive inhibitor binding sites in the open state ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}c). This explains why the noncompetitive inhibitors preferentially interact with AMPARs in the closed state^[@ref17],[@ref75]^ and supports the previously proposed inhibition mechanism,^[@ref17]^ where the inhibitors occupying their binding sites act as "wedges" to prevent the conformational changes (kinking of the M3 helices at the A618 gating hinge in subunits B and D) associated with channel opening.^[@ref25]^ Additionally, the rearrangements of the TMD collar region during gating explain why mutations around pre-M1 in both AMPARs and NMDARs have profound effects on gating and cause human neurological diseases.^[@ref64],[@ref66],[@ref76]−[@ref78]^

![Noncompetitive inhibitor binding site and gating. (a) Crystal structure of GluA2 in the closed, resting state bound to the noncompetitive inhibitor perampanel (PMP) (GluA2~PMP~, PDB entry 5L1F), with the ATD layer removed, viewed parallel to the membrane. The four PMP molecules bound in the ion channel extracellular collar are shown as space-filling models. (b) Close-up of the PMP binding site within GluA2~PMP~ subunit B. The PMP molecule is shown in ball-and-stick representation. (c) Close-up of the same region in the open state GluA2--STZ~Glu+CTZ~ structure. The green asterisk indicates the region where PMP binds in GluA2~PMP~, which in the open state is occupied by the extracellular portion of M3 kinked at the A618 gating hinge.](bi-2017-008918_0007){#fig7}

ATD: The Gating Modulatory Domain {#sec7}
=================================

While the role of the ATD in AMPAR gating has remained mysterious, recent cryo-EM structures show that it certainly does not stand by idly; it appears to act as a modulator and communicator of the conformational changes that are happening in the receptor below. The ATD is connected to the LBD through the ATD--S1 linker, which is truncated in many structural studies to help reduce structural heterogeneity and flexibility. However, regardless of the wild-type or truncated state of this linker, early cryo-EM and X-ray crystallography studies put forth the idea that the ATDs would splay apart (i.e., rupture the cross-dimer interface) upon desensitization to help uncouple the ligand-bound state of the receptor from the channel. However, recent biophysical studies using cross-linking^[@ref79]^ and fluorescence resonance energy transfer^[@ref80]^ suggested that the ATDs maintain their tetrameric assembly and do not splay apart during gating. Indeed, the recent crystal^[@ref16]^ and cryo-EM^[@ref25],[@ref26]^ structures show that the changes in the LBDs described above alter the top of the LBD layer ([Movie 7](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00891/suppl_file/bi7b00891_si_007.avi) and [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}), resulting in rigid-body movement of the entire ATD tetramer during gating ([Movie 8](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00891/suppl_file/bi7b00891_si_008.avi) and [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}). During the C to P~A~ transition, there is little overall movement of the LBD tetramer ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}a), and thus, the ATD layer stays nearly the same ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}d). However, upon activation and channel opening, the tops of the A and C subunit LBDs rotate by 6° ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}b), resulting in a rigid-body rotation of the entire ATD tetramer by 8° ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}e). Even larger changes are observed during desensitization, when a 14° rotation of the tops of the A and C subunit LBDs ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}c) results in a dramatic 18° rigid-body rotation of the entire ATD tetramer ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}f). Consequently, profound changes in the LBD layer domain arrangement and interfaces during gating do not seem to alter the tetrameric arrangement of AMPAR ATDs. The entire ATD layer rotates as a rigid body ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}d--f), not only emphasizing the important role of the ATD in AMPAR assembly^[@ref7]^ but also providing a way for modulating AMPAR function through interaction with trans-synaptic molecular elements.^[@ref81],[@ref82]^

![Overall movements of the LBD and ATD tetramers during gating. Superposition of (a--c) LBD and (d--f) ATD tetramers from GluA2--GSG1L~ZK-1~ (blue, closed state) and (a and d) GluA2~NOW~ (green, pre-active state), (b and e) GluA2--STZ~Glu+CTZ~ (magenta, open state), or (c and f) GluA2--GSG1L~Quis~ (orange, desensitized state) viewed extracellularly along the axis of the overall 2-fold receptor symmetry (black ovals). Cα atoms of T394 (a--c) and N10 (d--f) are shown as spheres of the corresponding color, connected by straight lines. Relative motions of the top portions of the LBDs and rigid-body rotations of the ATD tetramer are indicated by red arrows.](bi-2017-008918_0008){#fig8}

We hypothesize that the ATD splaying observed in earlier crystallographic and cryo-EM studies^[@ref13],[@ref18],[@ref83]^ is an artifact of the sample preparation and treatment, as receptors with wild-type linkers also maintain their ATD layer integrity during desensitization, as evidenced by cryo-EM data from a recent study.^[@ref49]^ In addition, the splaying apart of ATDs unlikely happens *in vivo*, given the crowded synaptic space^[@ref84]^ and numerous cross-synaptic interactions that modulate iGluR function.^[@ref85]−[@ref87]^

Conclusions and Outlook {#sec8}
=======================

A couple of years ago the structural determinants of iGluR gating remained ambiguous. Now, a collection of recent crystallography and cryo-EM AMPAR structures allow structural visualization of the entire iGluR gating mechanism for the first time ([Movies 1--9](#notes1){ref-type="notes"}). However, many key questions remain unanswered. How conserved is the AMPAR gating mechanism in different iGluR subtypes? What are the structural determinants of multiple conductance levels? What is the exact structural mechanism of iGluR assembly? What are structural mechanisms of small-molecule interactions with the gating machinery of iGluRs? What are the energetic determinants along the iGluR gating transitions? How do different auxiliary subunits affect the structural mechanisms of iGluR gating? What are the structures of iGluR CTDs, and how do these domains contribute to receptor function in neurons? We expect the coming years will be an exciting time to address these and many other questions about iGluR structure and function and that building upon the recent structures not only enhances our understanding of the molecular bases of excitatory neurotransmission but also will contribute to drug design targeting iGluRs in neurological diseases.
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